title: Changes in apoprotein distribution between lipoprotein classes of hypercholesterolemic rats treated with ascorbate.
abstract: It is known that ascorbate has a lipid lowering effect, accompanied by a drop of apo B, in rats fed a diet enriched with 1.5% of cholesterol (Nath diet). In order to better clarify the role exerted by ascorbate in lipid metabolism, the effect of ascorbate administration on apolipoprotein pattern in rats fed the Nath diet was investigated. Wistar male rats fed for two months the Nath diet were treated i.p. with 60 mg/kg of body weight of ascorbate for 10 days. Blood collection before and after the treatment was performed by intracardiac puncture. Lipoproteins were prepared by preparative ultracentrifugation and their apoprotein content was obtained by densitometric scanning of the apoprotein electhrophoretic pattern. The decrease of total plasma cholesterol and triglycerides and of cholesterol, triglycerides and protein content of all plasma lipoproteins observed in ascorbate treated rats, is accompanied by a marked modification of the apolipoprotein pattern of all lipoprotein classes studied, with an increase of apo E content in VLDL-IDL and LDL fractions (135 and 44% respectively), and a decrease of C (37%), AI (70%) and B (37.5%) apoproteins in VLDL-IDL and of apo C (36%) in LDL. On the contrary, in HDL fraction ascorbate induces an increase of C apoproteins (26%) and a decrease of E and B apoproteins (47% and 71% respectively). The data reported clearly show that in hypercholesterolemic rats the lipid lowering effect of ascorbate administration, is accompanied by a marked modification of the apoprotein pattern of all lipoprotein classes studied.
authors.affiliation: Istituto di Scienze Fisiologiche Umane, Facoltà di Medicina e Chirurgia, Università degli Studi di Napoli Federico II, Italy.
authors.forename: M
authors.initials: M
authors.lastname: Santillo
authors.forename: P
authors.initials: P
authors.lastname: Mondola
authors.forename: F
authors.initials: F
authors.lastname: Santangelo
authors.forename: A
authors.initials: A
authors.lastname: Gioielli
authors.forename: S
authors.initials: S
authors.lastname: Iossa
authors.forename: A
authors.initials: A
authors.lastname: Basilisco
authors.forename: R
authors.initials: R
authors.lastname: De Mercato
mesh_terms: D000818:Animals; D001053:Apolipoproteins / Q000097:blood*; D001205:Ascorbic Acid / Q000008:administration & dosage / Q000494:pharmacology*; D002784:Cholesterol / Q000097:blood; D002791:Cholesterol, Dietary / Q000008:administration & dosage; D006937:Hypercholesterolemia / Q000097:blood* / Q000188:drug therapy; D008074:Lipoproteins / Q000097:blood*; D008075:Lipoproteins, HDL / Q000097:blood; D008077:Lipoproteins, LDL / Q000097:blood; D008079:Lipoproteins, VLDL / Q000097:blood; D008297:Male; D051381:Rats; D017208:Rats, Wistar; D014280:Triglycerides / Q000097:blood
chemical_list: D001053:Apolipoproteins; D002791:Cholesterol, Dietary; D008074:Lipoproteins; D008075:Lipoproteins, HDL; D008077:Lipoproteins, LDL; D008079:Lipoproteins, VLDL; D014280:Triglycerides; D002784:Cholesterol; D001205:Ascorbic Acid